» Articles » PMID: 34361444

Comparison of the Toxicity of Pristine Graphene and Graphene Oxide, Using Four Biological Models

Abstract

There are numerous applications of graphene in biomedicine and they can be classified into several main areas: delivery systems, sensors, tissue engineering and biological agents. The growing biomedical field of applications of graphene and its derivates raises questions regarding their toxicity. We will demonstrate an analysis of the toxicity of two forms of graphene using four various biological models: zebrafish () embryo, duckweed (), human HS-5 cells and bacteria (). The toxicity of pristine graphene (PG) and graphene oxide (GO) was tested at concentrations of 5, 10, 20, 50 and 100 µg/mL. Higher toxicity was noted after administration of high doses of PG and GO in all tested biological models. Hydrophilic GO shows greater toxicity to biological models living in the entire volume of the culture medium (zebrafish, duckweed, ). PG showed the highest toxicity to adherent cells growing on the bottom of the culture plates-human HS-5 cells. The differences in toxicity between the tested graphene materials result from their physicochemical properties and the model used. Dose-dependent toxicity has been demonstrated with both forms of graphene.

Citing Articles

SARS-CoV-2 pseudovirus dysregulates hematopoiesis and induces inflammaging of hematopoietic stem and progenitor cells.

Chae D, Park H, Kim K, Yu A, Park J, Oh M Exp Mol Med. 2025; .

PMID: 40025168 DOI: 10.1038/s12276-025-01416-1.


The Delivery of Mimic miRNA-7 into Glioblastoma Cells and Tumour Tissue by Graphene Oxide Nanosystems.

Kutwin M, Sosnowska-Lawnicka M, Nasilowska B, Lange A, Wierzbicki M, Jaworski S Nanotechnol Sci Appl. 2024; 17:167-188.

PMID: 39280996 PMC: 11402368. DOI: 10.2147/NSA.S469193.


Biomedical applications of graphene-based nanomaterials: recent progress, challenges, and prospects in highly sensitive biosensors.

Baruah A, Newar R, Das S, Kalita N, Nath M, Ghosh P Discov Nano. 2024; 19(1):103.

PMID: 38884869 PMC: 11183028. DOI: 10.1186/s11671-024-04032-6.


Graphene oxide and oxidized carbon nanodiscs as biomedical scaffolds for the targeted delivery of quercetin to cancer cells.

Zygouri P, Tsiodoulos G, Angelidou M, Papanikolaou E, Athinodorou A, Simos Y Nanoscale Adv. 2024; 6(11):2860-2874.

PMID: 38817436 PMC: 11134231. DOI: 10.1039/d3na00966a.


The cytocompatibility of graphene oxide as a platform to enhance the effectiveness and safety of silver nanoparticles through in vitro studies.

Strojny-Cieslak B, Jaworski S, Wierzbicki M, Pruchniewski M, Sosnowska-Lawnicka M, Szczepaniak J Environ Sci Pollut Res Int. 2023; 31(60):67317-67338.

PMID: 37824053 PMC: 11685253. DOI: 10.1007/s11356-023-30151-1.


References
1.
Tucureanu V, Matei A, Avram A . FTIR Spectroscopy for Carbon Family Study. Crit Rev Anal Chem. 2016; 46(6):502-20. DOI: 10.1080/10408347.2016.1157013. View

2.
Patlolla A, Rondalph J, Tchounwou P . Biochemical and Histopathological Evaluation of Graphene Oxide in Sprague-Dawley Rats. Austin J Environ Toxicol. 2018; 3(1). PMC: 5831506. View

3.
Wang Z, Wang Z . Nanoparticles induced embryo-fetal toxicity. Toxicol Ind Health. 2020; 36(3):181-213. DOI: 10.1177/0748233720918689. View

4.
Strojny B, Kurantowicz N, Sawosz E, Grodzik M, Jaworski S, Kutwin M . Long Term Influence of Carbon Nanoparticles on Health and Liver Status in Rats. PLoS One. 2015; 10(12):e0144821. PMC: 4681315. DOI: 10.1371/journal.pone.0144821. View

5.
Pelin M, Fusco L, Leon V, Martin C, Criado A, Sosa S . Differential cytotoxic effects of graphene and graphene oxide on skin keratinocytes. Sci Rep. 2017; 7:40572. PMC: 5227695. DOI: 10.1038/srep40572. View